A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus

Abstract The emerging variants of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in pandemic call for the urgent development of universal corona virus disease 2019 (COVID‐19) vaccines which could be effective for both wild‐type SARS‐CoV‐2 and mutant strains. In the current study, we fo...

Full description

Bibliographic Details
Main Authors: Cai He, Jingyun Yang, Xuemei He, Weiqi Hong, Hong Lei, Zimin Chen, Guobo Shen, Li Yang, Jiong Li, Zhenling Wang, Xiangrong Song, Wei Wang, Guangwen Lu, Xiawei Wei
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:MedComm
Subjects:
bivalent vaccine
recombinant protein
SARS‐CoV‐2
variant
Online Access:https://doi.org/10.1002/mco2.72

Internet

https://doi.org/10.1002/mco2.72

Similar Items